Stage IVC Squamous Cell Carcinoma of the Larynx Active Not Recruiting Phase 2 Trials for Afatinib (DB08916)

IndicationStatusPhase
DBCOND0029837 (Stage IVC Squamous Cell Carcinoma of the Larynx)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01824823Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of RecurrenceTreatment